Diagnostic Accuracy of a Blood-Based Biomarker Panel for Colorectal Cancer Detection: A Pilot Study

Area of Science:

• Oncology
• Molecular Diagnostics
• Biomarker Discovery

Background:

• Colorectal cancer (CRC) remains a significant global health challenge.
• Current CRC screening methods face compliance issues due to invasiveness.
• There is a critical need for validated, minimally invasive blood-based biomarkers for CRC screening.

Purpose of the Study:

• To assess the diagnostic accuracy of four blood-based biomarkers for colorectal cancer (CRC).
• To evaluate the performance of individual biomarkers and their combined diagnostic potential.
• To explore novel minimally invasive screening tools for CRC detection.

Main Methods:

• A case-control study involving 124 CRC cases and 124 matched controls.
• Plasma samples were analyzed for methylated Septin-9 (mSEPT9), IGFBP2, DKK3, and PKM2.
• Diagnostic accuracy was determined using receiver operating characteristic (ROC) curves and area under the curve (AUC).

Main Results:

• Individual biomarker diagnostic accuracies ranged from 50.8% (PKM2) to 69.7% (IGFBP2).
• The combined biomarker panel achieved an AUC of 74.4%, outperforming most individual markers.
• The biomarker panel demonstrated potential for improved CRC detection accuracy.

Conclusions:

• The evaluated blood-based biomarkers show promise for a minimally invasive CRC detection tool.
• This approach could potentially enhance screening adherence and facilitate earlier CRC detection.
• Further development could lead to improved patient outcomes and survivorship through better screening compliance.